FindMyKOL
Clinical trialNCT07121972RecruitingInterventional

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

SponsorUniversity of California, San FranciscoEnrollment400Breast Cancer RiskCancer Risk
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Diego

    San Diego, California, United States

    Not, yet, recruiting
  • University of California, San Francisco

    San Francisco, California, United States

    Adam Yala, PhDMaggie Chung, MD
    Recruiting
  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

    Not, yet, recruiting
  • University of Massachusetts Memorial Medical Center

    Worcester, Massachusetts, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Nov 2025
Primary completion
31 Jan 2027
Completion
31 Jan 2027
Last update posted
10 Nov 2026
Registered enrollment
400
Registry id
NCT07121972

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.